nach oben

Erschienen in:

06.05.2014 | Fortbildung

Endarterektomie oder Stent?

Therapie von Karotisstenosen

verfasst von: Prof. Dr. Dr. Dipl.-Ing. Bernhard Widder

Erschienen in: NeuroTransmitter | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die meisten Metaanalysen und Übersichtsarbeiten der letzten Jahre vermitteln den Eindruck, dass das „Rennen“ zwischen der Karotis-Endarterektomie und dem Karotis-Stenting zugunsten des operativen Eingriffs gelaufen ist [19]. Trotzdem lohnt es sich, einen näheren Blick auf die Frage zu werfen, mit welcher Methode und nicht zuletzt wann überhaupt bei Karotisstenosen Interventionen durchgeführt werden sollten.

Abu Rahma AF, Metz MJ, Robinson PA. Natural history of > or = 60% asymptomatic carotid stenosis in patients with contralateral carotid occlusion. Ann Surg 2003; 238: 551–561

Abu Rahma AF, Stone PA, Abu-Halimah S, Welch CA. Natural history of carotid artery occlusion contralateral to carotid endarterectomy. J Vasc Surg 2006; 44: 62–66CrossRef

Albuquerque LC, Narvaes LB, Maciel AA, Staub H, Friedrich M, Filho JR, Marques MB, Rohde LE. Intraplaque hemorrhage assessed by high-resolution magnetic resonance imaging and C-reactive protein in carotid atherosclerosis. J Vasc Surg 2007; 46: 1130–1137PubMedCrossRef

AMWF-Leitlinie Extracranielle Carotisstenose; Diagnostik, Therapie und Nachsorge. http://www.awmf.org/leitlinien/detail/ll/004-028.html

Baker WH, Howard VJ, Howard G, Toole JF. Effect of contralateral occlusion on long-term efficacy of endarterectomy in the asymptomatic carotid atherosclerosis study (ACAS). ACAS Investigators. Stroke 2000; 31: 2330–2334PubMedCrossRef

Barnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998; 339: 1415–25PubMedCrossRef

Blaser T, Hofmann K, Buerger T, Effenberger O, Wallesch CW, Goertler M. Risk of stroke, transient ischemic attack, and vessel occlusion before endarterectomy in patients with symptomatic severe carotid stenosis. Stroke 2002; 33: 1057–1062PubMedCrossRef

Bokkers RP, van Osch MJ, van der Worp HB, de Borst GJ, Mali WP, Hendrikse J. Symptomatic carotid artery stenosis: impairment of cerebral autoregulation measured at the brain tissue level with arterial spin-labeling MR imaging. Radiology 2010; 256: 201–208PubMedCrossRef

Bonati LH, Ederle J, McCabe DJ, et al. Longterm risk of carotid restenosis in patients randomly assigned to endovascular treatment or endarterectomy in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trial. Lancet Neurol 2009; 8: 908–917PubMedCentralPubMedCrossRef

10.

Brott TG, Hobson RW II, Howard G, Roubin GS, Clark WM, Brooks W, Mackey A, Hill MD, Leimgruber PP, Sheffet AJ, Howard VJ, Moore WS, Voeks JH, Hopkins LN, Cutlip DE, Cohen DJ, Popma JJ, Ferguson RD, Cohen SN, Blackshear JL, Silver FL, Mohr JP, Lal BK, Meschia JF. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 2010; 363: 11–23PubMedCentralPubMedCrossRef

11.

Brown MM, Rogers J, Bland JM. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet 2001; 357: 1729–37CrossRef

12.

Eckstein HH, Ringleb P, Allenberg JR, Berger J, Fraedrich G, Hacke W, Hennerici M, Stingele R, Fiehler J, Zeumer H, Jansen O. Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial. Lancet Neuro. 2008; 7: 893CrossRef

13.

Ederle J, Bonati LH, Dobson J, Featherstone RL, Gaines PA, Beard JD, Venables GS, Markus HS, Clifton A, Sandercock P, Brown MM. Endovascular treatment with angioplasty or stenting versus endarterectomy in patients with carotid artery stenosis in the Carotid And Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trial. Lancet Neurol. 2009; 8: 898–907PubMedCentralPubMedCrossRef

14.

Ederle J, Dobson J, Featherstone RL, Bonati LH, van der Worp HB, de Borst GJ, Lo TH, Gaines P, Dorman PJ, Macdonald S, Lyrer PA, Hendriks JM, McCollum C, Nederkoorn PJ, Brown MM. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial. Lancet. 2010; 375: 985–997PubMedCrossRef

15.

European Carotid Surgery Trialists’ Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998; 351: 1379–87CrossRef

16.

Fasseas P, Brilakis ES, Leybishkis B, Cohen M, Sokil AB, Wolf N, Dorn RL, Roberts A, Van Decker W. Association of carotid artery intimamedia thickness with complex aortic atherosclerosis in patients with recent stroke. Angiology 2002; 53: 185–189PubMedCrossRef

17.

Furie KL et al. Guidelines for the Prevention of Stroke in Patients with Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals from the American Heart Association/ American Stroke Association. Stroke 2011; 42: 227–276PubMedCrossRef

18.

Gremmel T, Steiner S, Seidinger D, Koppensteiner R, Panzer S, Kopp CW. Smoking promotes clopidogrel-mediated platelet inhibition in patients receiving dual antiplatelet therapy. Thromb Res 2009; 124: 588–591PubMedCrossRef

19.

Gröschel K. Has surgery won the race against endovascular treatment for carotid stenosis? Lancet Neurol 2010; 9; 332–333PubMedCrossRef

20.

Gurm HS, Yadav JS, Fayad P, et al, for the SAPPHIRE Investigators. Longterm results of carotid stenting versus endarterectomy in highrisk patients. N Engl J Med 2008; 358: 1572–79PubMedCrossRef

21.

Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J, Thomas D. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 2004; 363: 1491–1502PubMedCrossRef

22.

Hauth EA, Jansen C, Drescher R, Schwartz M, Forsting M, Jaeger HJ, Mathias KD. MR and clinical follow-up of diffusion-weighted cerebral lesions after carotid artery stenting. Am J Neuroradiol 2005; 26: 2336–2341PubMed

23.

Jayasooriya G, Thapar A, Shalhoub J, Davies AH. Silent cerebral events in asymptomatic carotid stenosis. J Vasc Surg 2011; 54: 227–236PubMedCrossRef

24.

King A, Serena J, Bornstein NM, Markus HS. Does impaired cerebrovascular reactivity predict stroke risk in asymptomatic carotid stenosis? A prospective substudy of the asymptomatic carotid emboli study. Stroke 2011; 42: 1550–1555PubMedCrossRef

25.

Li WJ, Zhang HY, Miao CL, Tang RB, DU X, Shi JH, Ma CS. Cigarette smoking inhibits the anti-platelet activity of aspirin in patients with coronary heart disease. Chin Med J 2011; 124; 1569–1572PubMed

26.

Liapis CD, Kakisis JD, Kostakis AG. Carotid stenosis: factors affecting symptomatology. Stroke 2001; 32: 2782–2786PubMedCrossRef

27.

Liu ZJ, Fu WG, Guo ZY, Shen LG, Shi ZY, Li JH. Updated systematic review and meta-analysis of randomized clinical trials comparing carotid artery stenting and carotid endarterectomy in the treatment of carotid stenosis. Ann Vasc Surg 2012; 26: 576–590PubMedCrossRef

28.

Macdonald S. Carotid artery stenting trials: conduct, results, critique, and current recommendations. Cardiovasc Intervent Radiol 2012; 35: 15–29PubMedCrossRef

29.

Markus H, Cullinane M. Severely impaired cerebrovascular reactivity predicts stroke and TIA risk in patients with carotid artery stenosis and occlusion. Brain 2001; 124: 457–467PubMedCrossRef

30.

Mas JL, Trinquart L, Leys D, Albucher JF, Rousseau H, Viguier A, Bossavy JP, Denis B, Piquet P, Garnier P, Viader F, Touze E, Julia P, Giroud M, Krause D, Hosseini H, Becquemin JP, Hinzelin G, Houdart E, Henon H, Neau JP, Bracard S, Onnient Y, Padovani R, Chatellier G. Endarterectomy versus angioplasty in patients with symptomatic severe carotid stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial. Lancet Neurol 2008; 7: 885–892PubMedCrossRef

31.

Merckel LG, Van der Heijden J, Jongen LM, van Es HW, Prokop M, Waaijer A. Effect of stenting on cerebral CT perfusion in symptomatic and asymptomatic patients with carotid artery stenosis. Am J Neuroradiol 2012; 33: 280–285PubMedCrossRef

32.

MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 2004; 363: 1491–1502CrossRef

33.

Nandalur KR, Hardie AD, Raghavan P, Schipper MJ, Baskurt E, Kramer CM. Composition of the stable carotid plaque: insights from a multidetector computed tomography study of plaque volume. Stroke 2007; 38: 935–940PubMedCentralPubMedCrossRef

34.

Petrik PV, Gelabert HA, Moore WS, Quinones-Baldrich W, Law MM. Cigarette smoking accelerates carotid artery intimal hyperplasia in a dose-dependent manner. Stroke 1995; 26: 1409–1414PubMedCrossRef

35.

Prabhakaran S, Rundek T, Ramas R, Elkind MS, Paik MC, Boden-Albala B, Sacco RL. Carotid plaque surface irregularity predicts ischemic stroke: the northern Manhattan study. Stroke 2006; 37: 2696–2701PubMedCentralPubMedCrossRef

36.

Ringleb PA, Allenberg J, Bruckmann H, et al. 30-day results from the SPACE trial of stentprotected angioplasty versus carotid endarterectomy in symptomatic patients: a randomized non-inferiority trial. Lancet 2006; 368: 1239–47 NEUROTRANSMITTER 2014; 25 (4) 3PubMedCrossRef

37.

Rosenkranz M, Thomalla G, Havemeister S, Wittkugel O, Cheng B, Krutzelmann A, Fiehler J, Gerloff C. Older age and greater carotid intima-media thickness predict ischemic events associated with carotid-artery stenting. Cerebrovasc Dis 2010; 30: 567–572PubMedCrossRef

38.

Rosenthal D, Archie JP, Garcia-Rinaldi R, et al. Carotid patch angioplasty: immediate and long-term results. J Vasc Surg 1990; 12: 326–333PubMedCrossRef

39.

Rothwell PM, Gutnikov SA, Eliasziw M, et al, for the Carotid Endarterectomy Trialists’ Collaboration: pooled analysis of individual patient data from randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003; 361: 107–16PubMedCrossRef

40.

Rothwell PM, Goldstein LB. Carotid endarterectomy for asymptomatic carotid stenosis: asymptomatic carotid surgery trial. Stroke 2004; 35: 2425–2427PubMedCrossRef

41.

Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ. Sex difference in the effect of time from symptoms to surgery on benefit from carotid endarterectomy for transient ischemic attack and nondisabling stroke. Stroke 2004; 35: 2855–2861PubMedCrossRef

42.

Sabeti S, Schlager O, Exner M, Mlekusch W, Amighi J, Dick P, Maurer G, Huber K, Koppensteiner R, Wagner O, Minar E, Schillinger M. Progression of carotid stenosis detected by duplex ultrasonography predicts adverse outcomes in cardiovascular high-risk patients. Stroke 2007; 38: 2887–2894PubMedCrossRef

43.

Setacci C, Chisci E, de Donato G et al. Carotid artery stenting in a single center: are six years of experience enough to achieve the standard of care? Eur J Vasc Endovasc Surg 2007; 34: 655–662PubMedCrossRef

44.

Silver FL, Mackey A, Clark WM, Brooks W, Timaran CH, Chiu D, Goldstein LB, Meschia JF, Ferguson RD, Moore WS, Howard G, Brott TG. Safety of stenting and endarterectomy by symptomatic status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST). Stroke 2011; 42: 675–680PubMedCentralPubMedCrossRef

45.

Shaalan WE, Cheng H, Gewertz B, McKinsey JF, Schwartz LB, Katz D, Cao D, Desai T, Glagov S, Bassiouny HS. Degree of carotid plaque calcification in relation to symptomatic outcome and plaque inflammation. J Vasc Surg 2004; 40: 262–269PubMedCrossRef

46.

Spence JD, Eliasziw M, Di Cicco M, Hackam DG, Galil R, Lohmann T. Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy. Stroke 2002; 33: 2916–2922PubMedCrossRef

47.

Spence JD, Tamayo A, Lownie SP, Ng WP, Ferguson GG. Absence of microemboli on transcranial Doppler identifies low-risk patients with asymptomatic carotid stenosis. Stroke 2005; 36: 2373–2378PubMedCrossRef

48.

Wasser K, Pilgram-Pastor SM, Schnaudigel S, Stojanovic T, Schmidt H, Knauf J, Groschel K, Knauth M, Hildebrandt H, Kastrup A. New brain lesions after carotid revascularization are not associated with cognitive performance. J Vasc Surg 2011; 53: 61–70PubMedCrossRef

49.

Widder B, Görtler M. Doppler- und Duplexsonographie der hirnversorgenden Arterien. 6. Auflage. Springer, Heidelberg 2004CrossRef

50.

Wimmer NJ, Yeh RW, Cutlip DE, Mauri L. Risk prediction for adverse events after carotid artery stenting in higher surgical risk patients. Stroke 2012; 43: 3218–3224PubMedCrossRef

51.

Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004; 351: 1493–501PubMedCrossRef

Titel: Endarterektomie oder Stent?
Therapie von Karotisstenosen
verfasst von: Prof. Dr. Dr. Dipl.-Ing. Bernhard Widder
Publikationsdatum: 06.05.2014
Verlag: Urban & Vogel
Erschienen in: NeuroTransmitter / Ausgabe 5/2014
Print ISSN: 1436-123X
Elektronische ISSN: 2196-6397
DOI: https://doi.org/10.1007/s15016-014-0625-5

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

23.04.2024 | Demenz | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Endarterektomie oder Stent?

Therapie von Karotisstenosen

Zusammenfassung

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2014

Elektronische Gesundheitskarte kommt voran

„Dieses Buch war mir ein Bedürfnis“

GOÄ korrekt auslegen (IV)

Lang wirksamer Dopaminagonist

Produkteinführung Prodigy

Depression – das bin doch nicht ICH!

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie